AXDX logo

Accelerate Diagnostics (AXDX) EBITDA

Annual EBITDA

-$49.77 M
+$6.03 M+10.80%

December 31, 2023

Summary

Performance

1-Year Change

+10.8%

3-Year Change

+16.57%

5-Year Change

+34.03%

15-Year Change

+18.86%

AXDX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.01%
AXDX annual EBITDA is higher than 33.01% of companies in Healthcare sector

High & Low

All-time High

$4.20 M
AXDX annual EBITDA is currently -1285.02% below its historical high of $4.20 million

3-Year Low

-$59.59 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
AXDX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
AXDX next annual earnings announcement is scheduled for Mar 28, 2025

OtherAXDXprofitabilitymetrics:

Annual Revenue

$12.06 M
AXDX annual revenue is $12.06 million

Annual Net Income

-$61.62 M
AXDX annual net profit is -$61.62 million

Annual EBIT

-$53.02 M
AXDX annual earnings before interest & taxes is -$53.02 million

Annual EPS

-$4.94
AXDX annual earnings per share is -$4.94

Quarterly EBITDA

-$10.17 M
-$2.05 M-25.19%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

AXDX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.43%
AXDX quarterly EBITDA is higher than 35.43% of companies in Healthcare sector

High & Low

All-time High

$4.06 M
AXDX quarterly EBITDA is currently -350.26% below its historical high of $4.06 million

3-Year Low

-$29.79 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AXDX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
AXDX next earnings announcement is scheduled for Mar 28, 2025

OtherAXDXprofitabilitymetrics:

Quarterly Revenue

$2.98 M
AXDX quarterly revenue is $2.98 million

Quarterly Net Income

-$14.64 M
AXDX quarterly net profit is -$14.64 million

Quarterly EBIT

-$11.05 M
AXDX quarterly earnings before interest & taxes is -$11.05 million

Quarterly EPS

-$0.59
AXDX quarterly earnings per share is -$0.59

TTM EBITDA

-$38.70 M
-$14.23 M-58.16%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

AXDX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.86%
AXDX TTM EBITDA is higher than 36.86% of companies in Healthcare sector

High & Low

All-time High

$5.28 M
AXDX TTM EBITDA is currently -832.60% below its historical high of $5.28 million

3-Year Low

-$71.22 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AXDX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
AXDX next earnings announcement is scheduled for Mar 28, 2025

OtherAXDXprofitabilitymetrics:

TTM Revenue

$11.91 M
AXDX TTM revenue is $11.91 million

TTM Net Income

-$53.45 M
AXDX TTM net profit is -$53.45 million

TTM EBIT

-$42.13 M
AXDX TTM earnings before interest & taxes is -$42.13 million

TTM EPS

-$2.64
AXDX TTM earnings per share is -$2.64

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$49.77 M
AXDX annual EBITDA is -$49.77 million

Annual Net Income

-$61.62 M
AXDX annual net profit is -$61.62 million

Annual Interest Expense

$7.74 M
AXDX annual interest expense is $7.74 million

Annual Income Tax

$850.00 K
AXDX annual income tax is $850.00 thousand

Annual D&A

$3.25 M
AXDX annual depreciation & amortization is $3.25 million

AXDX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.8%0.0%0.0%
3 y3 years+16.6%0.0%0.0%
5 y5 years+34.0%0.0%0.0%

AXDX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+16.5%-350.3%+65.9%-58.2%+45.7%
5 y5-yearat high+26.3%-350.3%+65.9%-58.2%+45.7%
alltimeall time-1285.0%+34.0%-350.3%+65.9%-832.6%+48.7%

Accelerate Diagnostics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$10.17 M(+25.2%)
-$38.70 M(+58.2%)
Jun 2024
-
-$8.12 M(-25.6%)
-$24.47 M(-47.0%)
Mar 2024
-
-$10.92 M(+15.1%)
-$46.13 M(-7.3%)
Dec 2023
-$49.77 M(-10.8%)
-$9.49 M(-333.5%)
-$49.77 M(-5.6%)
Sep 2023
-
$4.06 M(-113.6%)
-$52.73 M(-26.0%)
Jun 2023
-
-$29.79 M(+104.5%)
-$71.22 M(+21.9%)
Mar 2023
-
-$14.56 M(+17.0%)
-$58.43 M(+4.7%)
Dec 2022
-$55.80 M(-6.4%)
-$12.45 M(-13.7%)
-$55.80 M(-10.6%)
Sep 2022
-
-$14.43 M(-15.1%)
-$62.40 M(+19.7%)
Jun 2022
-
-$16.99 M(+42.4%)
-$52.12 M(+0.2%)
Mar 2022
-
-$11.93 M(-37.4%)
-$52.03 M(-12.7%)
Dec 2021
-$59.59 M(-0.1%)
-$19.05 M(+359.2%)
-$59.59 M(+8.9%)
Sep 2021
-
-$4.15 M(-75.5%)
-$54.72 M(-15.4%)
Jun 2021
-
-$16.91 M(-13.2%)
-$64.67 M(+3.7%)
Mar 2021
-
-$19.49 M(+37.5%)
-$62.34 M(+4.5%)
Dec 2020
-$59.66 M(-11.7%)
-$14.17 M(+0.5%)
-$59.66 M(-4.6%)
Sep 2020
-
-$14.10 M(-3.3%)
-$62.52 M(-3.6%)
Jun 2020
-
-$14.58 M(-13.2%)
-$64.87 M(-3.1%)
Mar 2020
-
-$16.80 M(-1.4%)
-$66.95 M(-0.9%)
Dec 2019
-$67.56 M(-10.4%)
-$17.04 M(+3.6%)
-$67.56 M(-1.7%)
Sep 2019
-
-$16.45 M(-1.3%)
-$68.73 M(-2.1%)
Jun 2019
-
-$16.66 M(-4.3%)
-$70.21 M(-3.7%)
Mar 2019
-
-$17.41 M(-4.3%)
-$72.93 M(-3.3%)
Dec 2018
-$75.44 M(+23.0%)
-$18.21 M(+1.6%)
-$75.44 M(+3.8%)
Sep 2018
-
-$17.93 M(-7.5%)
-$72.66 M(+2.0%)
Jun 2018
-
-$19.38 M(-2.7%)
-$71.21 M(+5.4%)
Mar 2018
-
-$19.93 M(+29.1%)
-$67.57 M(+10.2%)
Dec 2017
-$61.34 M(-3.8%)
-$15.43 M(-6.4%)
-$61.34 M(+0.3%)
Sep 2017
-
-$16.48 M(+4.7%)
-$61.18 M(-0.4%)
Jun 2017
-
-$15.74 M(+15.0%)
-$61.40 M(-2.4%)
Mar 2017
-
-$13.69 M(-10.3%)
-$62.92 M(-1.5%)
Dec 2016
-$63.76 M(+45.9%)
-$15.27 M(-8.6%)
-$63.85 M(+4.4%)
Sep 2016
-
-$16.70 M(-3.3%)
-$61.16 M(+10.8%)
Jun 2016
-
-$17.26 M(+18.0%)
-$55.17 M(+10.9%)
Mar 2016
-
-$14.63 M(+16.3%)
-$49.76 M(+13.9%)
Dec 2015
-$43.70 M(+45.5%)
-$12.57 M(+17.3%)
-$43.70 M(+11.9%)
Sep 2015
-
-$10.72 M(-9.5%)
-$39.07 M(+5.9%)
Jun 2015
-
-$11.84 M(+38.2%)
-$36.90 M(+11.7%)
Mar 2015
-
-$8.57 M(+7.9%)
-$33.03 M(+10.0%)
Dec 2014
-$30.04 M(+101.3%)
-$7.94 M(-7.1%)
-$30.04 M(+10.7%)
Sep 2014
-
-$8.54 M(+7.1%)
-$27.14 M(+21.8%)
Jun 2014
-
-$7.98 M(+43.1%)
-$22.29 M(+23.8%)
Mar 2014
-
-$5.58 M(+10.6%)
-$18.00 M(+20.7%)
Dec 2013
-$14.92 M(+344.4%)
-$5.04 M(+36.6%)
-$14.92 M(+51.1%)
Sep 2013
-
-$3.69 M(+0.1%)
-$9.88 M(+31.7%)
Jun 2013
-
-$3.69 M(+47.8%)
-$7.50 M(+25.6%)
Mar 2013
-
-$2.50 M(+89.6%)
-$5.97 M(+45.6%)
Dec 2012
-$3.36 M(+6.6%)
-
-
Oct 2012
-
-$1.32 M(-39.1%)
-$4.10 M(+30.2%)
Jul 2012
-$3.15 M(+502.3%)
-$2.16 M(+525.9%)
-$3.15 M(+161.8%)
Apr 2012
-
-$345.20 K(+23.8%)
-$1.20 M(+29.7%)
Jan 2012
-
-$278.90 K(-23.7%)
-$927.70 K(+46.6%)
Dec 2011
-$523.00 K(+240.7%)
-
-
Oct 2011
-
-$365.30 K(+70.9%)
-$632.60 K(+312.1%)
Jul 2011
-$153.50 K(-117.6%)
-$213.70 K(+206.2%)
-$153.50 K(-107.9%)
Apr 2011
-
-$69.80 K(-530.9%)
$1.94 M(+14.8%)
Jan 2011
-
$16.20 K(-85.8%)
$1.69 M(+25.5%)
Oct 2010
-
$113.80 K(-93.9%)
$1.35 M(+54.0%)
Jul 2010
$873.30 K
$1.88 M(-686.8%)
$873.30 K(-179.7%)
DateAnnualQuarterlyTTM
Apr 2010
-
-$320.10 K(-2.1%)
-$1.10 M(+17.3%)
Jan 2010
-
-$327.10 K(-8.6%)
-$933.90 K(+42.3%)
Oct 2009
-
-$358.00 K(+294.7%)
-$656.30 K(+60.4%)
Jul 2009
-$409.00 K(-71.5%)
-$90.70 K(-42.6%)
-$409.10 K(-42.2%)
Apr 2009
-
-$158.10 K(+219.4%)
-$707.40 K(-16.3%)
Jan 2009
-
-$49.50 K(-55.3%)
-$845.20 K(-21.8%)
Oct 2008
-
-$110.80 K(-71.5%)
-$1.08 M(-24.6%)
Jul 2008
-$1.43 M(-20.4%)
-$389.00 K(+31.5%)
-$1.43 M(-0.8%)
Apr 2008
-
-$295.90 K(+3.8%)
-$1.44 M(-9.2%)
Jan 2008
-
-$285.20 K(-38.5%)
-$1.59 M(+118.2%)
Oct 2007
-
-$463.40 K(+15.8%)
-$729.20 K(-9.4%)
Jul 2007
-$1.80 M(-37.7%)
-$400.20 K(-9.5%)
-$804.70 K(-20.8%)
Apr 2007
-
-$442.10 K(-176.7%)
-$1.02 M(-24.1%)
Jan 2007
-
$576.50 K(-207.0%)
-$1.34 M(-50.2%)
Oct 2006
-
-$538.90 K(-11.8%)
-$2.69 M(-7.0%)
Jul 2006
-$2.89 M(+47.9%)
-$611.00 K(-20.1%)
-$2.89 M(-2.6%)
Apr 2006
-
-$764.80 K(-0.8%)
-$2.97 M(+8.7%)
Jan 2006
-
-$770.60 K(+4.0%)
-$2.73 M(+22.3%)
Oct 2005
-
-$741.10 K(+7.5%)
-$2.23 M(+14.2%)
Jul 2005
-$1.95 M(+31.1%)
-$689.20 K(+30.5%)
-$1.95 M(+23.6%)
Apr 2005
-
-$528.00 K(+93.8%)
-$1.58 M(+14.5%)
Jan 2005
-
-$272.40 K(-41.3%)
-$1.38 M(-8.8%)
Oct 2004
-
-$463.80 K(+46.4%)
-$1.51 M(+2.4%)
Jul 2004
-$1.49 M(-9.3%)
-$316.70 K(-3.4%)
-$1.48 M(-31.8%)
Apr 2004
-
-$328.00 K(-19.0%)
-$2.17 M(+5.5%)
Jan 2004
-
-$405.00 K(-5.3%)
-$2.05 M(+8.6%)
Oct 2003
-
-$427.80 K(-57.4%)
-$1.89 M(+15.1%)
Jul 2003
-$1.64 M(+174.2%)
-$1.00 M(+368.4%)
-$1.64 M(+157.4%)
Apr 2003
-
-$214.50 K(-11.5%)
-$638.00 K(+14.5%)
Jan 2003
-
-$242.30 K(+34.3%)
-$557.30 K(+6.2%)
Oct 2002
-
-$180.40 K(>+9900.0%)
-$524.70 K(-12.4%)
Jul 2002
-$598.90 K(-25.2%)
-$800.00(-99.4%)
-$598.90 K(-26.5%)
Apr 2002
-
-$133.80 K(-36.2%)
-$814.60 K(-3.7%)
Jan 2002
-
-$209.70 K(-17.6%)
-$846.30 K(-9.3%)
Oct 2001
-
-$254.60 K(+17.6%)
-$932.60 K(+16.5%)
Jul 2001
-$800.30 K(-43.7%)
-$216.50 K(+30.8%)
-$800.40 K(-32.6%)
Apr 2001
-
-$165.50 K(-44.1%)
-$1.19 M(-25.5%)
Jan 2001
-
-$296.00 K(+141.8%)
-$1.59 M(-6.5%)
Oct 2000
-
-$122.40 K(-79.7%)
-$1.71 M(-3.9%)
Jul 2000
-$1.42 M(-909.4%)
-$603.80 K(+5.4%)
-$1.77 M(+78.3%)
Apr 2000
-
-$572.60 K(+40.7%)
-$995.50 K(+90.4%)
Jan 2000
-
-$407.00 K(+112.5%)
-$522.90 K(+376.2%)
Oct 1999
-
-$191.50 K(-209.1%)
-$109.80 K(-159.7%)
Jul 1999
$175.60 K(-95.8%)
$175.60 K(-275.6%)
$183.80 K(-137.4%)
Apr 1999
-
-$100.00 K(-1739.3%)
-$491.80 K(-134.9%)
Jan 1999
-
$6100.00(-94.0%)
$1.41 M(-58.3%)
Oct 1998
-
$102.10 K(-120.4%)
$3.38 M(-22.9%)
Jul 1998
$4.20 M(+320.0%)
-$500.00 K(-127.8%)
$4.38 M(-17.0%)
Apr 1998
-
$1.80 M(-8.9%)
$5.28 M(+36.1%)
Jan 1998
-
$1.98 M(+78.7%)
$3.88 M(+103.7%)
Oct 1997
-
$1.11 M(+176.5%)
$1.91 M(+73.3%)
Jul 1997
$1.00 M(-23.1%)
$400.00 K(0.0%)
$1.10 M(-15.4%)
Apr 1997
-
$400.00 K(>+9900.0%)
$1.30 M(+8.3%)
Jan 1997
-
$0.00(-100.0%)
$1.20 M(-14.3%)
Oct 1996
-
$300.00 K(-50.0%)
$1.40 M(+7.7%)
Jul 1996
$1.30 M
$600.00 K(+100.0%)
$1.30 M(+85.7%)
Apr 1996
-
$300.00 K(+50.0%)
$700.00 K(+75.0%)
Jan 1996
-
$200.00 K(0.0%)
$400.00 K(+100.0%)
Oct 1995
-
$200.00 K
$200.00 K

FAQ

  • What is Accelerate Diagnostics annual EBITDA?
  • What is the all time high annual EBITDA for Accelerate Diagnostics?
  • What is Accelerate Diagnostics annual EBITDA year-on-year change?
  • What is Accelerate Diagnostics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Accelerate Diagnostics?
  • What is Accelerate Diagnostics quarterly EBITDA year-on-year change?
  • What is Accelerate Diagnostics TTM EBITDA?
  • What is the all time high TTM EBITDA for Accelerate Diagnostics?
  • What is Accelerate Diagnostics TTM EBITDA year-on-year change?

What is Accelerate Diagnostics annual EBITDA?

The current annual EBITDA of AXDX is -$49.77 M

What is the all time high annual EBITDA for Accelerate Diagnostics?

Accelerate Diagnostics all-time high annual EBITDA is $4.20 M

What is Accelerate Diagnostics annual EBITDA year-on-year change?

Over the past year, AXDX annual EBITDA has changed by +$6.03 M (+10.80%)

What is Accelerate Diagnostics quarterly EBITDA?

The current quarterly EBITDA of AXDX is -$10.17 M

What is the all time high quarterly EBITDA for Accelerate Diagnostics?

Accelerate Diagnostics all-time high quarterly EBITDA is $4.06 M

What is Accelerate Diagnostics quarterly EBITDA year-on-year change?

Over the past year, AXDX quarterly EBITDA has changed by $0.00 (0.00%)

What is Accelerate Diagnostics TTM EBITDA?

The current TTM EBITDA of AXDX is -$38.70 M

What is the all time high TTM EBITDA for Accelerate Diagnostics?

Accelerate Diagnostics all-time high TTM EBITDA is $5.28 M

What is Accelerate Diagnostics TTM EBITDA year-on-year change?

Over the past year, AXDX TTM EBITDA has changed by $0.00 (0.00%)